Biomarkers of Pathophysiology in Hypertrophic Cardiomyopathy: Implications for Clinical Management and Prognosis

European Heart Journal - United Kingdom
doi 10.1093/eurheartj/ehn538
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Hypertrophic Cardiomyopathy From a to Z: Genetics, Pathophysiology, Imaging, and Management

Radiographics
MedicineNuclear MedicineRadiologyImaging
2016English

Tachycardia Mediated Cardiomyopathy: Pathophysiology, Mechanisms, Clinical Features and Management

International Journal of Cardiology
Cardiovascular MedicineCardiology
2014English

Massive Transfusion and Coagulopathy: Pathophysiology and Implications for Clinical Management

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2006English

Mid-Regional Proatrial Natriuretic Peptide for Predicting Prognosis in Hypertrophic Cardiomyopathy

Heart
Cardiovascular MedicineCardiology
2019English

Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy

Circulation
Cardiovascular MedicinePhysiologyCardiology
2016English

Spotlight on Management of Hypertrophic Cardiomyopathy

Cardiometry
Cardiovascular MedicineCardiology
2014English

Prognosis in Hypertrophic Cardiomyopathy Observed in a Large Clinic Population

American Journal of Cardiology
Cardiovascular MedicineCardiology
1993English

Pathophysiology of Atopic Dermatitis and Psoriasis: Implications for Management in Children

Children
2019English

Hypertrophic Cardiomyopathy

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy